Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27.8M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
10.4M
-
Shares change
-
+490K
-
Total reported value, excl. options
-
$530M
-
Value change
-
+$30.3M
-
Put/Call ratio
-
2.63
-
Number of buys
-
57
-
Number of sells
-
-60
-
Price
-
$50.85
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q4 2014
141 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q4 2014.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.4M shares
of 27.8M outstanding shares and own 37.51% of the company stock.
Largest 10 shareholders include FMR LLC (2.14M shares), Consonance Capital Management LP (1.7M shares), EAGLE ASSET MANAGEMENT INC (1.11M shares), Apex Capital Management (587K shares), State Street Corp (522K shares), BlackRock Fund Advisors (507K shares), VANGUARD GROUP INC (263K shares), Marshall Wace LLP (195K shares), BlackRock Institutional Trust Company, N.A. (169K shares), and WALL STREET ASSOCIATES (158K shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.